Emily Olsen

Also: AI-enabled documentation tool DeepScribe raises $30 million, cancer risk stratification platform PreciseDx scores $10.75 million and care navigation startup HeyRenee brought in $4.4 million.

Health tech companies raised nearly $40 billion last year, according to Silicon Valley Bank's Healthcare Investments and Exits Report. IPOs were also up, but those companies didn't fare as well in the public markets.

Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.

Headspace said the deal will improve its ability to personalize users' experiences.

Also: Overjet hires Dr. Teresa Dolan as chief dental officer, Valo Health appoints Dr. Dave Morris as chief medical officer and AliveCor adds four new people to its executive team.

Impeto’s SUDOSCAN technology for monitoring peripheral neuropathies is included in Withings’ recently announced Body Scan smart scale.

The company plans to use the funding to expand its commercial team, scale operations and develop new products.

The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.

The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.

During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.